Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma

Affiliations

¹ Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China. Electronic address: modunchang2018@163.com.
² Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.

Comment

Dun-Chang Mo et al. Lancet Oncol. 2023 Jun.

. 2023 Jun;24(6):e230.

doi: 10.1016/S1470-2045(23)00211-5.

¹ Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China. Electronic address: modunchang2018@163.com.
² Radiotherapy Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.

No abstract available

Conflict of interest statement

We declare no competing interests.

Radiotherapy for children and adolescents with early-stage classical Hodgkin lymphoma - Authors' reply.
Körholz D, Mauz-Körholz C, Wallace WH, Landman-Parker J, Kluge R, Hasenclever D. Körholz D, et al. Lancet Oncol. 2023 Jun;24(6):e231. doi: 10.1016/S1470-2045(23)00235-8. Lancet Oncol. 2023. PMID: 37269849 No abstract available.

Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study.
Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T, Rajić V, Ramsay AD, Stoevesandt D, Uyttebroeck A, Vordermark D, Körholz D, Hasenclever D, Wallace WH, Kluge R. Mauz-Körholz C, et al. Lancet Oncol. 2023 Mar;24(3):252-261. doi: 10.1016/S1470-2045(23)00019-0. Lancet Oncol. 2023. PMID: 36858722 Clinical Trial.